HPGD Antikörper (AA 55-160)

Produktnummer ABIN761711

Produktdetails anti-HPGD Antikörper

Target: HPGD (Hydroxyprostaglandin Dehydrogenase 15-(NAD) (HPGD))

Bindungsspezifität: AA 55-160

Reaktivität: Human, Ratte

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser HPGD Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), ELISA, Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p)), Immunohistochemistry (Frozen Sections) (IHC (fro))

Kreuzreaktivität: Human, Ratte

Homologie: Mouse,Cow,Pig,Horse,Rabbit

Aufreinigung: Purified by Protein A.

Immunogen: KLH conjugated synthetic peptide derived from human Prostaglandin dehydrogenase 1

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: WB 1:300-5000
ELISA 1:500-1000
IHC-P 1:200-400
IHC-F 1:100-500
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 1 μg/μL

Buffer: 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.

Konservierungsmittel: ProClin

Vorsichtsmaßnahmen: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Lagerung: 4 °C,-20 °C

Informationen zur Lagerung: Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.

Haltbarkeit: 12 months

Referenzen für anti-HPGD Antikörper (ABIN761711)

Hu, Li, Maskey, Xu, Peng, Tian, Li, Yang: "15-PGDH expression as a predictive factor response to neoadjuvant chemotherapy in advanced gastric cancer." in: International journal of clinical and experimental pathology, Vol. 8, Issue 6, pp. 6910-8, (2015) (PubMed).

Wei, Yu, Shi, Zhang, Lian, Li, Shen, Xing, Zhu: "15-PGDH/15-KETE plays a role in hypoxia-induced pulmonary vascular remodeling through ERK1/2-dependent PAR-2 pathway." in: Cellular signalling, Vol. 26, Issue 7, pp. 1476-1488, (2014) (PubMed).

Details zu HPGD

Target: HPGD (Hydroxyprostaglandin Dehydrogenase 15-(NAD) (HPGD))

Andere Bezeichnung: Prostaglandin Dehydrogenase 1 (HPGD Produkte)

Synonyme: CBR antikoerper, SDR21C1 antikoerper, hCBR1 antikoerper, 15-PGDH antikoerper, PGDH antikoerper, PGDH1 antikoerper, PHOAR1 antikoerper, SDR36C1 antikoerper, MGC80546 antikoerper, MGC79454 antikoerper, AV026552 antikoerper, carbonyl reductase 1 antikoerper, 15-hydroxyprostaglandin dehydrogenase antikoerper, hydroxyprostaglandin dehydrogenase 15-(NAD) antikoerper, 15-hydroxyprostaglandin dehydrogenase L homeolog antikoerper, hydroxyprostaglandin dehydrogenase 15 (NAD) antikoerper, CBR1 antikoerper, HPGD antikoerper, hpgd.L antikoerper, hpgd antikoerper, pgdh antikoerper, Hpgd antikoerper, PTRG_03214 antikoerper, VDBG_09957 antikoerper

Hintergrund:

Synonyms: PGDH, PGDH1, PHOAR1, 15-PGDH, SDR36C1, 15-hydroxyprostaglandin dehydrogenase [NAD(+)], Prostaglandin dehydrogenase 1, HPGD

Background: Prostaglandin inactivation. Contributes to the regulation of events that are under the control of prostaglandin levels. Catalyzes the NAD-dependent dehydrogenation of lipoxin A4 to form 15-oxo-lipoxin A4. Inhibits in vivo proliferation of colon cancer cells.

Gen-ID: 3248

UniProt: P15428